Cargando…
Inhibition of RORα/γ suppresses atherosclerosis via inhibition of both cholesterol absorption and inflammation
OBJECTIVE: Cardiovascular diseases (CVDs) are the leading cause of mortality in Western countries. Atherosclerosis is a multi-step inflammatory disease characterized at early stages by accumulation of cholesterol in the arterial wall followed by recruitment of immune cells. We sought to determine if...
Autores principales: | Billon, Cyrielle, Sitaula, Sadichha, Burris, Thomas P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5034492/ https://www.ncbi.nlm.nih.gov/pubmed/27689012 http://dx.doi.org/10.1016/j.molmet.2016.07.001 |
Ejemplares similares
-
Metabolic Characterization of a Novel RORα Knockout Mouse Model without Ataxia
por: Billon, Cyrielle, et al.
Publicado: (2017) -
Therapeutic Effect of a Synthetic RORα/γ
Agonist in an Animal Model of Autism
por: Wang, Yongjun, et al.
Publicado: (2015) -
Transcriptional Interactomic Inhibition of RORα Suppresses Th17-Related Inflammation
por: Ho, Chun-Chang, et al.
Publicado: (2021) -
Targeting the cholesterol-RORα/γ axis inhibits colorectal cancer progression through degrading c-myc
por: Wang, Ying-Nan, et al.
Publicado: (2022) -
Pharmacological inhibition of REV-ERB stimulates differentiation, inhibits turnover and reduces fibrosis in dystrophic muscle
por: Welch, Ryan D., et al.
Publicado: (2017)